206 related articles for article (PubMed ID: 38201497)
1. Amino Acid Profiles in the Biological Fluids and Tumor Tissue of CRC Patients.
Santos MD; Barros I; Brandão P; Lacerda L
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201497
[TBL] [Abstract][Full Text] [Related]
2. [Integrated analysis of serum untargeted metabolomics and targeted bile acid metabolomics for identification of diagnostic biomarkers for colorectal cancer].
Wang X; Zhu Y; Zhou H; Huang Z; Chen H; Zhang J; Yang S; Chen G; Zhang Q
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Mar; 43(3):443-453. PubMed ID: 37087590
[TBL] [Abstract][Full Text] [Related]
3. A quantitative multimodal metabolomic assay for colorectal cancer.
Farshidfar F; Kopciuk KA; Hilsden R; McGregor SE; Mazurak VC; Buie WD; MacLean A; Vogel HJ; Bathe OF
BMC Cancer; 2018 Jan; 18(1):26. PubMed ID: 29301511
[TBL] [Abstract][Full Text] [Related]
4. Global and targeted serum metabolic profiling of colorectal cancer progression.
Long Y; Sanchez-Espiridion B; Lin M; White L; Mishra L; Raju GS; Kopetz S; Eng C; Hildebrandt MAT; Chang DW; Ye Y; Liang D; Wu X
Cancer; 2017 Oct; 123(20):4066-4074. PubMed ID: 28640361
[TBL] [Abstract][Full Text] [Related]
5. Metabolomics analyses of cancer tissue from patients with colorectal cancer.
Kang C; Zhang J; Xue M; Li X; Ding D; Wang Y; Jiang S; Chu FF; Gao Q; Zhang M
Mol Med Rep; 2023 Nov; 28(5):. PubMed ID: 37772396
[TBL] [Abstract][Full Text] [Related]
6. Profiling the metabolic disorder and detection of colorectal cancer based on targeted amino acids metabolomics.
Yang Y; Wang Z; Li X; Lv J; Zhong R; Gao S; Zhang F; Chen W
J Transl Med; 2023 Nov; 21(1):824. PubMed ID: 37978537
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers in bladder cancer: A metabolomic approach using in vitro and ex vivo model systems.
Rodrigues D; Jerónimo C; Henrique R; Belo L; de Lourdes Bastos M; de Pinho PG; Carvalho M
Int J Cancer; 2016 Jul; 139(2):256-68. PubMed ID: 26804544
[TBL] [Abstract][Full Text] [Related]
8. Identification of differential metabolic characteristics between tumor and normal tissue from colorectal cancer patients by gas chromatography-mass spectrometry.
Ning W; Li H; Meng F; Cheng J; Song X; Zhang G; Wang W; Wu S; Fang J; Ma K; Yang J; Pei D; Dong F
Biomed Chromatogr; 2017 Nov; 31(11):. PubMed ID: 28475217
[TBL] [Abstract][Full Text] [Related]
9. Global metabolomics profiling of colorectal cancer in Malaysian patients.
Amir Hashim NA; Ab-Rahim S; Wan Ngah WZ; Nathan S; Ab Mutalib NS; Sagap I; A Jamal AR; Mazlan M
Bioimpacts; 2021; 11(1):33-43. PubMed ID: 33469506
[No Abstract] [Full Text] [Related]
10. Metabolomic Profiling Identified Serum Metabolite Biomarkers and Related Metabolic Pathways of Colorectal Cancer.
Zhang C; Zhou S; Chang H; Zhuang F; Shi Y; Chang L; Ai W; Du J; Liu W; Liu H; Zhou X; Wang Z; Hong T
Dis Markers; 2021; 2021():6858809. PubMed ID: 34917201
[TBL] [Abstract][Full Text] [Related]
11. Combination of GC-MS based metabolomics analysis with mouse xenograft models reveals a panel of dysregulated circulating metabolites and potential therapeutic targets for colorectal cancer.
Ni J; Chen Y; Li N; Sun D; Ju H; Chen Z
Transl Cancer Res; 2021 Apr; 10(4):1813-1825. PubMed ID: 35116504
[TBL] [Abstract][Full Text] [Related]
12. Characterizing metabolic changes in human colorectal cancer.
Williams MD; Zhang X; Park JJ; Siems WF; Gang DR; Resar LM; Reeves R; Hill HH
Anal Bioanal Chem; 2015 Jun; 407(16):4581-95. PubMed ID: 25943258
[TBL] [Abstract][Full Text] [Related]
13. Global serum metabolomics profiling of colorectal cancer.
Hashim NAA; Ab-Rahim S; Suddin LS; Saman MSA; Mazlan M
Mol Clin Oncol; 2019 Jul; 11(1):3-14. PubMed ID: 31289671
[TBL] [Abstract][Full Text] [Related]
14. Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection.
Ritchie SA; Ahiahonu PW; Jayasinghe D; Heath D; Liu J; Lu Y; Jin W; Kavianpour A; Yamazaki Y; Khan AM; Hossain M; Su-Myat KK; Wood PL; Krenitsky K; Takemasa I; Miyake M; Sekimoto M; Monden M; Matsubara H; Nomura F; Goodenowe DB
BMC Med; 2010 Feb; 8():13. PubMed ID: 20156336
[TBL] [Abstract][Full Text] [Related]
15. Plasma metabolomic profile in prostatic intraepithelial neoplasia and prostate cancer and associations with the prostate-specific antigen and the Gleason score.
Markin PA; Brito A; Moskaleva N; Lartsova EV; Shpot YV; Lerner YV; Mikhajlov VY; Potoldykova NV; Enikeev DV; La Frano MR; Appolonova SA
Metabolomics; 2020 Jun; 16(7):74. PubMed ID: 32556743
[TBL] [Abstract][Full Text] [Related]
16. [Development of a widely-targeted metabolomics method based on gas chromatography-mass spectrometry].
Wang YT; Yang Y; Sun XL; Ji J
Se Pu; 2023 Jun; 41(6):520-526. PubMed ID: 37259877
[TBL] [Abstract][Full Text] [Related]
17. NMR-based metabolomic techniques identify potential urinary biomarkers for early colorectal cancer detection.
Wang Z; Lin Y; Liang J; Huang Y; Ma C; Liu X; Yang J
Oncotarget; 2017 Dec; 8(62):105819-105831. PubMed ID: 29285295
[TBL] [Abstract][Full Text] [Related]
18. [Plasma metabolomics in a deep vein thrombosis rat model based on ultra-high performance liquid chromatography-electrostatic field orbitrap high resolution mass spectrometry].
Gu Y; Zang P; Li J; Yan Y; Wang J
Se Pu; 2022 Aug; 40(8):736-745. PubMed ID: 35903841
[TBL] [Abstract][Full Text] [Related]
19. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]